The space launch, pipeline and process services, and clinical laboratory services markets are integral to the future of global industries. With rapid advancements in technology, regulatory shifts, and increasing investments, businesses in these sectors must adopt innovative solutions to stay competitive
COPD Drug Market Opportunity & Clinical Pipeline Analysis @ http://www.reportsnreports.com/reports/280894-copd-drug-market-opportunity-clinical-pipeline-analysis.html “COPD Drug Market Opportunity & Clinical Pipeline Analysis” Report Highlight: • COPD Drug Market Overview • COPD Patient Base: Global, US & Europe • FDA & EMA Guidelines on Clinical Investigation of COPD Drugs • COPD Drug Clinical Pipeline by Phase & Country • COPD Drug in Development Phase: 174 • Majority of COPD Drugs in Preclinical Phase: 72 • Marketed COPD Drugs: 36 • Discontinued & Suspended COPD Drug Profiles
Pulmonary Drug Delivery Market & Clinical Pipeline Insight @ http://www.reportsnreports.com/reports/285693-pulmonary-drug-delivery-market-clinical-pipeline-insight.html The pulmonary technology offers an exclusive and inventive alternative for drug delivery as it allows for a systemic delivery of large and small molecule drugs through inhalation into the lungs. This mode of drug delivery have helped in reducing the adverse effects of low solubility and absorption of drugs which are present in the other therapies through the oral, intravenous and injection routes.
HIV Vaccine Market Opportunity & Clinical Pipeline Analysis @ http://www.reportsnreports.com/reports/276628-hiv-vaccine-market-opportunity-clinical-pipeline-analysis.html Ever since HIV was identified as the cause for AIDS 30 years ago, the HIV virus has become one of the greatest challenges of public health facing all countries of the world. According to UNAIDS, death due to AIDS was estimated to close to 1.6 million in 2012. There were 2.3 million new HIV infections, and about 35.3 million people currently living with HIV. Given the pace at which the HIV virus is spreading, it is most likely that AIDS would take more lives than any other infectious disease in the future years to come. Inspite of well-expanded programs of prevention and treatment which are currently enabling the stakeholders to address the illness and death associated with HIV and AIDS, the HIV vaccines is considered to be the best solution to end this disease successfully.
Research Beam added a report on “Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2015” Enquiry about report: http://www.researchbeam.com/clinical-chemistry-analyzers-medical-devices-pipeline-assessment-2015-market/enquire-about-report
Aarkstore.com announce a new report "Lung Cancer Therapeutic Antibodies: Pipeline, Strategies and Clinical" through its vast collection of market research report.
Aarkstore.com announce a new report "Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical" through its vast collection of market research report.
Bharatbook.com announces a 20% discount on a report "US Orphan Drug Clinical Pipeline Insight 2014" The report Highlight US Orphan Drug Market Insight & Orphan Drug Designation Criteria, Reimbursement Policy & FDA Regulatory Framework, US Orphan Drug Pipeline by Phase, Indication & Company.(Discount Valid till 31 Dec. 2014)
Renub Research (http://www.renub.com/hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php)has announced the addition of the "Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global" report to its offering
Renub Research (http://www.renub.com/hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php)has announced the addition of the "Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global" report to its offering
Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape. The current Hepatitis C treatment landscape consists of a combination of pegylated interferon, ribavirin and, in patients infected with genotype 1 hepatitis C, one of two direct-acting antiviral agents (DAAs). Browse full report @ http://bit.ly/1zyVhVi
Clinical IT Systems Pipeline Review, 2015 provides an overview of Clinical IT Systems currently in pipeline stage. Enquiry about report: http://www.researchbeam.com/clinical-it-systems-pipeline-review-2015-market/enquire-about-report
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Contact Lenses pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.
Companyprofilesandconferences.com glad to promote a new report on "Digna Biotech, S.L. - Product Pipeline Analysis" which are focuses on the development and commercialization of robust clinical therapeutic candidates through partnerships with pharmaceutical companies.
Bharatbook.com announces a report on “Global Orphan Drug Pipeline & Regulatory Insight 2015”. This report Highlights Global Orphan Drug Market Overview, In-depth Insight on Regulatory Framework & for Orphan Drugs by Region, Orphan Drug Designation Criteria & Reimbursement Policy by Region, Comprehensive Insight on Global Orphan Drug Clinical Pipeline
Stephen Berk, RPh Acting Chief California AIDS Drug Assistance Program Unit Clinical Pharmacy versus Pharmacy Pharmacy Attention is on the drug Clinical Pharmacy ...
Jsb Market Research’s latest report, “Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline” is a comprehensive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications. This pipeline is also benchmarked against its size across each segment compared to 2015 and 2016, and an assessment of the level of first-in-class innovation is provided. In addition, a detailed contextual analysis of the key drivers of this pipeline is provided, in addition to an assessment of companies present in the pipeline and historical deal value and volume.
Orphan Drugs for Cancer Pipeline Industry Analysis http://www.reportsnreports.com/reports/269589-orphan-drugs-for-cancer-pipeline-analysis.html . A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed for treating rare cancer diseases like solid tumor of the pancreas and thyroid, blood cancer, melanoma, and others.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vision Care pipeline products. Enquire About This Report @ http://www.bigmarketresearch.com/report-enquiry/389182
Download Sample Brochure @ http://bit.ly/2dEhRvj DelveInsight’s, “ Xerostomia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Xerostomia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Read Analysis @ http://bit.ly/2dwYulS
“Viral Conjunctivitis - Pipeline Review, H2 2014”, provides an overview of the Viral Conjunctivitis’s therapeutic pipeline. The report provides a snapshot of the global therapeutic landscape of Viral Conjunctivitis See Full Report: http://goo.gl/oCgbnw
Oncology clinical trial monitor market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to grow at a CAGR of 10.3% in the above-mentioned forecast period.
iGATE RESEARCH report entitled “Worldwide - Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019” provides an in-depth analysis of the drugs, pipeline drugs and the key players that will shape the future of Hepatitis C Drugs Market. This 113 page report with 27 Figures and 1 Table studies the Hepatitis C Drug Market Landscape. This Report is analyzed from four view points: Approved drugs sales, Pipeline drugs sales, Company Wise Clinical Trial Analysis and Deals and Acquisitions in Hepatitis C Landscape. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Hepatitis%20C%20Drugs%20Market%20and%20Pipeline%20Analysis
Allergan, Inc. (Allergan) is a global healthcare company. The company develops and commercializes novel pharmaceuticals, over-the-counter products, biologics and the medical devices addressing ophthalmic, neurological, medical aesthetic, medical dermatology, breast aesthetic, urological, and other specialty markets. The company’s research and development efforts focus on products and technologies related to wide range of specialty areas with significant unmet clinical needs. The company sells its products through a network of own distributors and direct subsidiaries in approximately 40 countries and through independent distributors in about 100 countries across the world. To View the report, visit the website at http://www.reportsandintelligence.com/allergan-inc-agn-product-pipeline-analysis-2014-update-reports-market
DelveInsights, Fatigue-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fatigue.
Big Market Research has announced a new report “Tuberculosis - Pipeline Review, H1 2015” Get Complete Report @ http://www.bigmarketresearch.com/tuberculosis-pipeline-review-h1-2015-market This report provides comprehensive information on the therapeutic development for Tuberculosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/316385 Big Market Research has announced a new report “Tuberculosis - Pipeline Review, H1 2015” Get Complete Report @ http://www.bigmarketresearch.com/tuberculosis-pipeline-review-h1-2015-market
Global Orphan Drug Pipeline Analysis” gives comprehensive insight on the various orphan designated drugs being developed for the treatment of rare disease. Research report covers all the orphan designated drugs being developed in various development phases.
Our products use R programming in clinical trials to automate some of the time-consuming manual processes involved in clinical research, drug and device development, and various stages of product life cycle. S
Big Market Research Announces new pharmaceuticals Report "Obesity Pipeline Market-symptoms, Analysis, portfolio, Forecasts 2015" Get Complete Report At: http://www.bigmarketresearch.com/obesity-pipeline-review-h1-2015-market This Report Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies and also helps to Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline. Enquire About this Report at: http://www.bigmarketresearch.com/report-enquiry/182244
Global Data's clinical trial report, Lung Injury Global Clinical Trials Review, H2, 2017 provides an overview of Lung Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Lung Injury.
Bigmarketresearch.com include new market research report “Tinnitus Pipeline Market- Portfolio, Analysis, Size, Share, Trends 2018” Get Complete Report At: http://www.bigmarketresearch.com/tinnitus-pipeline-review-h1-2015-market This report provides comprehensive information on the therapeutic development for Tinnitus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Enquire About this Report At: http://www.bigmarketresearch.com/report-enquiry/183902
Big Market Research announces a new Pharmaceuticals Report package "Leukodystrophies - Pipeline Market: Portfolio, Symptoms, Analysis, Size, Share, Forecasts 2018" Get Complete Report At: http://www.bigmarketresearch.com/leukodystrophies-pipeline-review-h1-2015-market This report provides comprehensive information on the therapeutic development for Leukodystrophies, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Enquire About this Report At: http://www.bigmarketresearch.com/report-enquiry/182245
Pipeline Analysis of Salivary Gland Cancer report covers emerging therapies for the cancer in active clinical development stages including early and late stage clinical trials. Medical centers throughout the world are researching the causes and treatment of salivary gland cancer. This is a challenging disease to study as it is not common. So, knowledge about treating these cancers with chemotherapy is still evolving. Chemo drugs such as gemcitabine, capecitabine and oxaliplatin are now being tested for clinical trials and may provide more options for people with advanced salivary gland cancer. Other treatments are- Surgery and Radiation therapy. For more information visit the below URL http://www.marketresearchhub.com/report/salivary-gland-cancer-pipeline-review-h2-2016-report.html
Bigtec labs is a multi-disciplinary company that focuses on the design, fabrication and testing of micro electromechanical systems, and handheld electronics, genomics and proteomics, biology and chemistry. The companys product pipeline consists of hand held point-of-care diagnostic equipment developed for malaria, hepatitis B, hepatitis C, chikungunya, HIV and HPV; water analysis and biofuels; and bio-films, rapid immunosensors and biomarker identification.
Genpro offers an experienced clinical data management services, team of managers and clinical data coordinators who comes with a life science background. They are trained in ICH/GCP as well as CFR PART 11 guidelines.
Lab21 Limited (Lab21) is a personalized healthcare company. The company offers diagnostic products and services and supports medical diagnostics, blood bank screening and drug discovery. Lab21serves pharmaceutical and diagnostic firms and international healthcare providers. Lab21s diagnostic product division manufactures immuno-diagnostic kits and reagents which is focused on infectious diseases for the blood banking and clinical markets.
SAS is one of the most popular data analysis tools used in the pharmaceutical industry. You will be amazed by the number of jobs that will pop up if you try to search for “SAS Jobs” online. Click here to get the best Clinical SAS Training Courses at the affordable cost price! Now!
Bharatbook.com announces a new report on "Banyan Biomarkers - Product Pipeline Analysis", It develops and markets biomarker diagnostic tests for the healthcare markets. Banyan creates point of care blood test to diagnose traumatic brain injury.
Bharat Book Bureau provides the report, on “Pipeline Insights: Surgical Wound Infections[2015]” The report provides a basic overview The pipeline assets across the Surgical Wound Infections. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. https://www.bharatbook.com/healthcare-market-research-reports-511550/surgical-wound-infections-pipeline-insights.html
The Syringes and Needles - Pipeline Review, 2015 report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. See Full Reports: http://goo.gl/C6sdPA
DelveInsights, Febrile Neutropenia-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Febrile Neutropenia.
Global Markets Directs, “Blepharitis - Pipeline Review, H1 2015”, provides an overview of the Blepharitiss therapeutic pipeline. For more details : http://goo.gl/cIIc6W
‘Hyperlipidemia - Pipeline Review, H2 2014’, provides an overview of the Hyperlipidemia’s therapeutic pipeline. For more details : http://goo.gl/UPSI67
ethical preconditions of clinical research are framed as an issue in medical epistemology ... clinical equipoise requires that research subjects be ...
Global Markets Directs, “Alopecia - Pipeline Review, H1 2015”, provides an overview of the Alopecias therapeutic pipeline. For more details : http://goo.gl/pfSTGL
Global Markets Directs, “Anthrax - Pipeline Review, H1 2015”, provides an overview of the Anthraxs therapeutic pipeline. For more details : http://goo.gl/2p990I
Global Markets Directs, “Endometriosis - Pipeline Review, H1 2015”, provides an overview of the Endometriosiss therapeutic pipeline. For more details : http://goo.gl/TV78Fz
“Crohn's Disease - Pipeline Review, H2 2014”, provides an overview of the Crohn's Diseases therapeutic pipeline. For more details : http://goo.gl/1kdcXk
Research Beam added a report on “Inhalers - Medical Devices Pipeline Assessment, 2015” Enquiry about report: http://www.researchbeam.com/inhalers-medical-devices-pipeline-assessment-2015-market/enquire-about-report
HepQuant, LLC (HepQuant) is a developmental stage company providing medical devices and tools for measuring liver function. Its products including HepQuant-STAT, HepQuant-SHUNT and HepQuant-FLOW. The products are liver function tests based on blood sampling and are yet to be put to clinical trials.